Big Data

Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial ResultsLavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results

Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results

LAV321demonstrated strong results in its third consecutive year of field trials in Europe REHOVOT, Israel, Nov. 19, 2024 /PRNewswire/ --…

8 months ago
Transforming Healthcare with Real-Time AI Image AnalyticTransforming Healthcare with Real-Time AI Image Analytic

Transforming Healthcare with Real-Time AI Image Analytic

Join us to discover how NVIDIA IGX and SDVoE enable seamless ultra-low latency solutions TAIPEI, Nov. 14, 2024 /PRNewswire/ --…

8 months ago
s.360 Life Underwriting SaaS is enhanced through Strategic Partnership with dacadoos.360 Life Underwriting SaaS is enhanced through Strategic Partnership with dacadoo

s.360 Life Underwriting SaaS is enhanced through Strategic Partnership with dacadoo

Samplemed Group, an international pioneer in integrated risk analysis and underwriting solutions, proudly announces its strategic partnership with dacadoo. This…

8 months ago
MintNeuro Secures £1M Investment to Advance Transformative Semiconductor Technology for Neural ImplantsMintNeuro Secures £1M Investment to Advance Transformative Semiconductor Technology for Neural Implants

MintNeuro Secures £1M Investment to Advance Transformative Semiconductor Technology for Neural Implants

 Latest capital raise will accelerate delivery of silicon roadmap to drive next-generation implantable devices for neurological applications LONDON, Nov. 12,…

8 months ago
Evogene Schedules Third Quarter 2024 Financial Results ReleaseEvogene Schedules Third Quarter 2024 Financial Results Release

Evogene Schedules Third Quarter 2024 Financial Results Release

Zoom conference call scheduled for November 21, 2024, 9:00 AM ET REHOVOT, Israel, Nov. 7, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq:…

8 months ago